M iddle-third clavicle fractures are among the most common upper extremity injuries managed by orthopaedic surgeons [5] . They most frequently result from high-energy or athletic trauma in young males, but they also occur as insufficiency fractures following lowenergy falls in the elderly [11] . Historically, the nonunion rate with conservative management was thought to be less than 1%. Malunion was considered unlikely to influence function, and patients with these injuries were expected to heal uneventfully [10, 15] . A 2009 Cochrane Review [7] comparing sling immobilization and figure-of-eight bandage treatment found no significant advantage for either method.
Several recent prospective studies reported nonunion rates of 15% to 20% and greater residual weakness, dysfunction, and dissatisfaction in patients with displaced middle-third clavicle A Note from the Editor-in-Chief: We are pleased to present to readers of Clinical Orthopaedics and Related Research 1 the next installment of Cochrane in CORR 1 , a regular feature. In this column, we will identify an abstract originally published in The Cochrane Library that we think is especially important, and Dr. Nathan Evaniew and his colleagues will provide expert perspective on it. One of the authors (MDM) certifies that he, or a member of his immediate family, has or will receive payments or benefits, during the study period, an amount in excess of USD 10,000-100,000 from Stryker (Mahwah, NJ, USA). One of the authors (ES) certifies that he, or a member of his immediate family, has or will receive payments or benefits, during the study period, an amount in excess of USD 10,000-100,000 from Stryker (Mahwah, NJ, USA fractures that were treated nonoperatively [2, 8] . Symptomatic malunion has been identified as a unique clinical entity with characteristic orthopaedic, neurologic, and cosmetic deficits [13] . Operative treatment with plates and screws or intramedullary devices may lead to higher scores on disease-specific functional outcome instruments, but there are risks for infection, wound breakdown, and hardware irritation requiring subsequent removal [2] . In order to fully inform patients and clinicians about the benefits and harms of treatment, this Cochrane Review considered the results of all published randomized and quasirandomized clinical trials comparing surgical and nonoperative management for displaced or angulated middle third clavicle fractures.
Upon Closer Inspection
Seven of the eight trials reported functional outcomes using either the Constant score or the DASH. The Constant score is a 100-point scoring system in which 35 points are derived from patient self-assessment [3] , and the DASH is a 30-item patientadministered instrument divided into physical function, symptoms, and social domains [4] . Neither is validated as a disease-specific outcome measure for patients with clavicle fractures, but they are both commonly used in studies of upper extremity trauma [17] . This Cochrane Review did not find differences in functional outcomes between the groups treated surgically or nonoperatively.
The search strategy identified all published randomized and quasirandomized controlled trials. Randomization balances the known and unknown determinants of outcome between groups in order to minimize selection bias and differential treatment bias [1] . Quasirandomized methods of allocation such as by hospital chart number, alternation, or day of birth, may lead to exaggerated or inaccurate study results [1] . Of the eight included trials, five did not adequately report their methods of allocation, and four did not describe whether allocation was concealed. Still, the authors included a sensitivity analysis that found no change in the primary pooled estimates of the effect of treatment when the lower-quality trials were excluded.
Take-Home Messages
Given that the majority of displaced middle-third clavicle fractures affect young active males, early return to function is of substantial socioeconomic importance [12] . Most patients in this meta-analysis experienced similar functional outcomes regardless of whether they were treated operatively or nonoperatively, which contrasts with a similar recent meta-analysis that found marginally superior long-term outcomes with operative treatment [9] . We suspect the no-difference finding in the current Cochrane Review, in contrast to that earlier study [9] , can likely be explained by varying definitions of clinical significance and the inclusion of three additional trials. Neither meta-analysis incorporated a validated threshold of clinical importance, but both acknowledged that small statistically significant treatment effects may not be patient-important. The three additional trials had lower rates of symptomatic malunions in their nonoperative groups, which may have relatively improved the pooled functional outcome scores for non-operative treatment in this meta-analysis.
To date, all of the randomized trials have found that 15% to 20% of patients develop nonunion with nonoperative management, and that malunions are common with that approach, in contrast to nearly consistent achievement of union and a low frequency of major complications with operative treatment [9, 14] . Nonetheless, this meta-analysis failed to identify any advantages with operative management using validated functional outcome instruments. There may be some patients who would benefit from surgery. However, it remains unclear whether certain fracture characteristics like shortening, comminution, or acute scapular winging caused by translation of the distal fragment (medially, inferiorly, and anteriorly) can reliably predict patient-important functional outcomes following nonoperative management [6, 13, 16] . Factors such as concomitant polytrauma, functional demands, or cultural responses to pain and disability could potentially influence whether a surgical or nonoperative approach is more likely to result in a satisfied patient.
This Cochrane Review provides critical evidence-based insight into the management of displaced middle-third clavicle fractures, and clinicians must carefully integrate these findings with patient preferences during decision-making.
